Filing Details
- Accession Number:
- 0001261380-14-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-06 17:59:40
- Reporting Period:
- 2014-03-04
- Filing Date:
- 2014-03-06
- Accepted Time:
- 2014-03-06 17:59:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1006045 | Iridex Corp | IRIX | Electromedical & Electrotherapeutic Apparatus (3845) | 770210467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1256164 | A Garrett Garrettson | 1212 Terra Bella Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-04 | 11,250 | $6.39 | 41,049 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-04 | 4,993 | $9.22 | 36,056 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option Right to Buy | Disposition | 2014-03-04 | 11,250 | $0.00 | 11,250 | $6.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-09-22 | No | 4 | M | Direct |
Footnotes
- The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $9.13 to $9.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This option was granted pursuant to IRIDEX Corporation's incentive Director Option Plan and is exempt pursuant to Rule 16b-3.
- Shares subject to the option are fully vested and immediately exercisable.